MARK2 and psoriasis: In Figure 5C, signaling pathways associated with psoriasis (skin psoriasis or PsA) are displayed and include “negative regulation of cellular response to transforming growth factor beta stimulus” (p = 1.54 × 10–5), “transmembrane receptor protein serine/threonine kinase signaling pathway” (p = 1.69 × 10–5), “epithelial cell development” (p = 1.14 × 10–4), and “SMAD protein signal transduction” (p = 7.72 × 10–4).